EMFAT
Emerald Mutual Fund Advisers Trust’s Supernus Pharmaceuticals SUPN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-273,568
| Closed | -$9.26M | – | 240 |
|
|
2022
Q3 | $9.26M | Buy |
273,568
+212,873
| +351% | +$7.21M | 0.59% | 69 |
|
|
2022
Q2 | $1.76M | Buy |
+60,695
| New | +$1.76M | 0.1% | 137 |
|
|
2018
Q1 | – | Sell |
-457,407
| Closed | -$18.2M | – | 259 |
|
|
2017
Q4 | $18.2M | Sell |
457,407
-45,463
| -9% | -$1.81M | 0.72% | 43 |
|
|
2017
Q3 | $20.1M | Buy |
502,870
+95,610
| +23% | +$3.82M | 0.84% | 34 |
|
|
2017
Q2 | $17.6M | Buy |
+407,260
| New | +$17.6M | 0.77% | 52 |
|